The infusion pump market size is expected to see strong growth in the next few years. It will grow to $25.01 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for home infusion therapy, rising adoption of connected healthcare devices, expansion of chronic disease management programs, growing focus on interoperability with hospital systems, increasing investments in smart hospital infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising use of ambulatory and home-based infusion devices, growing integration of dose error reduction systems, expansion of wireless connectivity in infusion systems, enhanced focus on patient safety and accuracy.
The increasing prevalence of chronic diseases is anticipated to drive the growth of the infusion pump market in the coming years. Chronic diseases, also known as noncommunicable diseases (NCDs), are long-term health conditions that typically develop gradually over an extended period. The rising incidence of chronic conditions, such as cancer and diabetes, is largely attributed to lifestyle changes, sedentary behaviors, declining quality of life, and unhealthy eating habits. Infusion pumps are utilized to manage some of these chronic diseases by providing accurate dosing, precise fluid delivery, and tailored treatments. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that the number of individuals with chronic diseases globally would reach 142.66 million by 2050, an increase from 71.522 million in 2020. Additionally, the International Diabetes Federation, which represents over 230 national diabetes associations in more than 160 countries and territories, estimated that there would be 643 million diabetics worldwide by 2030, rising to 783 million by 2045. Consequently, the increasing prevalence of chronic diseases is expected to boost the growth of the infusion pump market.
Key players in the infusion pump market are also focusing on the development of infusion management software to gain a competitive advantage. Infusion management software comprises specialized computer programs designed to oversee and optimize the administration of fluids, medications, and other therapeutic agents via infusion pumps in healthcare settings. For instance, in June 2023, B. Braun Medical Inc., a US-based medical device manufacturing company, introduced the DoseTrac Enterprise Infusion Management Software. This advanced software offers healthcare organizations real-time views and retrospective reporting features, enabling them to manage their infusion pump fleets and related data effectively. The platform can connect up to 40,000 pumps across multiple facilities through a single application, facilitating centralized management regardless of fleet size or the number of locations. DoseTrac Enterprise aims to enhance data management and may reduce the clinical IT infrastructure needed for infusion pumps.
In November 2024, ICU Medical Inc., a United States-based manufacturer of medical equipment, entered into a partnership with Otsuka Pharmaceutical Factory, Inc. to reinforce the development and supply of infusion therapy solutions. Through this collaboration, ICU Medical and Otsuka seek to increase manufacturing capacity for infusion systems, improve supply chain resilience for essential infusion devices, and foster long-term innovation aimed at enhancing the safety and efficiency of infusion delivery. Otsuka Pharmaceutical Factory, Inc. is a Japan-based healthcare company specializing in the production of high-quality intravenous solutions and related therapeutic products.
Major companies operating in the infusion pump market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Smiths Medical Inc., Medtronic plc, Moog Inc., Terumo Corporation, Insulet Corporation, Boston Scientific Corporation, Tandem Diabetes Care Inc., InfuTronix Solutions LLC, Micrel Medical Devices SA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Mindray Medical International Limited, Caesarea Medical Electronics Ltd., Hospitech Respiration Ltd., IRadimed Corporation, Ivenix Inc., Sooil Development Co. Ltd., ZOLL Medical Corporation, Zyno Medical LLC.
North America was the largest region in the infusion pump market in 2025. The regions covered in the infusion pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infusion pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the infusion pump market by increasing costs of imported electronic modules, sensors, motors, tubing materials, and software components used across pump devices and consumables. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported components, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are increasing device acquisition costs and delaying upgrades. However, they are also encouraging local device assembly, regional component sourcing, and innovation in cost-efficient infusion pump designs.
The infusion pump market research report is one of a series of new reports that provides infusion pump market statistics, including infusion pump industry global market size, regional shares, competitors with a infusion pump market share, detailed infusion pump market segments, market trends and opportunities, and any further data you may need to thrive in the infusion pump industry. This infusion pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An infusion pump is a medical device utilized to deliver fluids, including medications or nutrients, into a patient's bloodstream in a controlled manner. The functioning of infusion pumps relies on a pump mechanism to regulate the rate and volume of fluid administered to the patient.
The primary product types of infusion pumps include accessories and consumables, along with devices. Accessories and consumables encompass additional components designed to enhance the performance or functionality of the medical device. Various pump types are available, such as volumetric infusion pumps, insulin pumps, enteral infusion pumps, syringe infusion pumps, ambulatory infusion pumps, PCA pumps, and implantable infusion pumps. These pumps utilize technologies ranging from traditional infusion pumps to specialty infusion pumps. Applications for infusion pumps cover areas such as chemotherapy or oncology, diabetes management, gastroenterology, pain management or analgesia, pediatrics or neonatology, hematology, and others. They are used across diverse settings, including hospitals, ambulatory care settings, specialty clinics, and home care settings.
The infusion pump market consists of sales of large volume infusion pump and elastomeric infusion pump. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Infusion Pump Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses infusion pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for infusion pump? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infusion pump market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Accessories And Consumables; Devices2) By Technology: Traditional Infusion Pumps; Specialty Infusion Pumps
3) By Application: Chemotherapy Or Oncology; Diabetes Management; Gastroenterology; Pain Management Or Analgesia; Pediatrics Or Neonatology; Hematology; Other Applications
4) By End User: Hospitals; Ambulatory Care Settings; Specialty Clinics; Home Care Settings
Subsegments:
1) By Accessories And Consumables: Infusion Sets; IV Catheters; Syringes; Safety Needles; Tubing2) By Devices: Volumetric Infusion Pumps; Syringe Pumps; Ambulatory Infusion Pumps; PCA (Patient-Controlled Analgesia) Pumps; Insulin Pumps; Enteral Infusion Pumps
Companies Mentioned: Becton Dickinson and Company; Baxter International Inc.; B. Braun Melsungen AG; ICU Medical Inc.; Fresenius Kabi AG; Smiths Medical Inc.; Medtronic plc; Moog Inc.; Terumo Corporation; Insulet Corporation; Boston Scientific Corporation; Tandem Diabetes Care Inc.; InfuTronix Solutions LLC; Micrel Medical Devices SA; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Mindray Medical International Limited; Caesarea Medical Electronics Ltd.; Hospitech Respiration Ltd.; IRadimed Corporation; Ivenix Inc.; Sooil Development Co. Ltd.; ZOLL Medical Corporation; Zyno Medical LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Infusion Pump market report include:- Becton Dickinson and Company
- Baxter International Inc.
- B. Braun Melsungen AG
- ICU Medical Inc.
- Fresenius Kabi AG
- Smiths Medical Inc.
- Medtronic plc
- Moog Inc.
- Terumo Corporation
- Insulet Corporation
- Boston Scientific Corporation
- Tandem Diabetes Care Inc.
- InfuTronix Solutions LLC
- Micrel Medical Devices SA
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Mindray Medical International Limited
- Caesarea Medical Electronics Ltd.
- Hospitech Respiration Ltd.
- IRadimed Corporation
- Ivenix Inc.
- Sooil Development Co. Ltd.
- ZOLL Medical Corporation
- Zyno Medical LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 17.2 Billion |
| Forecasted Market Value ( USD | $ 25.01 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |


